Free Trial

Encompass Health Corporation $EHC Stock Position Raised by Sequoia Financial Advisors LLC

Encompass Health logo with Medical background

Key Points

  • Sequoia Financial Advisors LLC increased its stake in Encompass Health Corporation by 221.0%, owning a total of 8,753 shares valued at over $1 million as per its recent SEC filing.
  • Multiple institutional investors, including Invesco Ltd. and T. Rowe Price, have also raised their holdings in Encompass Health, with hedge funds collectively owning 97.25% of the company's stock.
  • Encompass Health recently increased its quarterly dividend from $0.17 to $0.19 per share, indicating a focus on returning value to shareholders.
  • MarketBeat previews top five stocks to own in November.

Sequoia Financial Advisors LLC raised its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 221.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,753 shares of the company's stock after purchasing an additional 6,026 shares during the period. Sequoia Financial Advisors LLC's holdings in Encompass Health were worth $1,073,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Invesco Ltd. raised its stake in shares of Encompass Health by 5.1% during the 1st quarter. Invesco Ltd. now owns 5,818,783 shares of the company's stock worth $589,326,000 after purchasing an additional 282,532 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its stake in shares of Encompass Health by 25.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company's stock valued at $210,756,000 after acquiring an additional 424,691 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Encompass Health by 5.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,871,581 shares of the company's stock valued at $189,549,000 after acquiring an additional 93,992 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Encompass Health by 13.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,822,376 shares of the company's stock valued at $184,571,000 after acquiring an additional 211,707 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. raised its stake in shares of Encompass Health by 11.9% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,541,477 shares of the company's stock valued at $156,121,000 after acquiring an additional 163,400 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

EHC has been the topic of a number of recent analyst reports. Truist Financial raised their price objective on Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research note on Thursday, August 14th. Weiss Ratings reaffirmed a "buy (b+)" rating on shares of Encompass Health in a research report on Wednesday, October 8th. KeyCorp lifted their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a report on Tuesday, September 16th. UBS Group lifted their price objective on Encompass Health from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Thursday, October 2nd. Finally, Bank of America boosted their price target on Encompass Health from $145.00 to $160.00 and gave the company a "buy" rating in a research note on Wednesday, September 10th. One research analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $139.86.

Read Our Latest Research Report on EHC

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.00% of the stock is currently owned by insiders.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $124.55 on Friday. The firm has a market cap of $12.55 billion, a P/E ratio of 24.37, a P/E/G ratio of 2.15 and a beta of 0.93. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.86. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The firm has a 50 day simple moving average of $123.56 and a 200 day simple moving average of $117.15.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The company had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Sell-side analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were given a dividend of $0.19 per share. The ex-dividend date was Wednesday, October 1st. This is an increase from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. Encompass Health's dividend payout ratio is presently 14.87%.

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

See Also

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Encompass Health Right Now?

Before you consider Encompass Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.

While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.